Amgen Europe GmbH
Industry / private company
Location:
Zug,
Switzerland (CH)
ISNI: 0000000404762707
ROR: https://ror.org/045wjte67
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in Europe (2018)
Cavo M, Terpos E, Bargay J, Einsele H, Cavet J, Greil R, De Wit E
Journal article, Review article
Development and validation of cardiovascular risk scores for haemodialysis patients (2016)
Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, Stenvinkel P, et al.
Journal article
Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients (2016)
Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, et al.
Journal article
Development and validation of a predictive mortality risk score from a European hemodialysis cohort (2015)
Floege J, Gillespie IA, Kronenberg F, Anker SD, Gioni I, Richards S, Pisoni RL, et al.
Journal article
Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study (2015)
Gillespie IA, Macdougall IC, Richards S, Jones V, Marcelli D, Froissart M, Eckardt KU
Journal article
High cardiovascular event rates occur within the first weeks of starting hemodialysis (2015)
Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, et al.
Journal article